The world's first mRNA vaccine against a deadly disease

Published Date: 15 Mar 2023

A world first: A research team from Tel Aviv University and the Israel Institute of Biology has developed an anti-mRNA drug that is 100% effective against a single type of virus.

Read Full News

Latest News

China Steps Up Ebola Monitoring With Revised Prevention Plan

China on Tuesday issued a revised prevention and control plan for the Ebola epidemic, requiring ⁠close contacts of Ebola cases to undergo tracking and quarantined medical...

Kennedy Orders American Exposed to Hantavirus to Stay Quarantined Against Her Will, WSJ Reports

U.S. Health Secretary Robert F. Kennedy Jr. has ordered an American passenger exposed to hantavirus on a cruise ship to remain in quarantine despite medical advice and...

Rare Genetic Disorders in Children: What Raises Suspicion?

Experts outline the clinical features that may signal rare genetic disorders, helping pediatricians identify affected children, and accelerate specialist referrals.

Managing C difficile in IBD: New Guidance From the AGA

The co-occurrence of IBD and Clostridioides difficile poses unique diagnostic and management challenges. A new American Gastroenterological Association statement updates earlier 2017 guidance.

Mapping the Clitoris Changes Women's Health

A profound lack of anatomical research into the clitoris has left the medical community blind to the root causes of postpartum nerve damage and chronic pelvic pain.

Congo Ebola Response Strained a Month After WHO Declares International Emergency

Health workers battling an Ebola outbreak in eastern Democratic Republic of Congo lack the personnel to identify suspected cases, the ambulances to transport them and even...

Todays Updates

Committee Recommends Canada Not Permit Euthanasia Solely for Mental Illness

Euthanasia should not be allowed for people seeking to be killed by medical professionals exclusively for mental illness reasons, according to a report published on...

New Immune Therapy Boosts Disease Control in Prostate Cancer

An adenoviral-based immunotherapy improved disease-free survival in men with localized intermediate- or high-risk disease, but experts had reservations.

Todays Updates

Committee Recommends Canada Not Permit Euthanasia Solely for Mental Illness

Euthanasia should not be allowed for people seeking to be killed by medical professionals exclusively for mental illness reasons, according to a report published on...

New Immune Therapy Boosts Disease Control in Prostate Cancer

An adenoviral-based immunotherapy improved disease-free survival in men with localized intermediate- or high-risk disease, but experts had reservations.

Latest News

China on Tuesday issued a revised prevention and control plan for the Ebola epidemic, requiring ⁠close contacts of Ebola cases to undergo tracking and quarantined medical...

U.S. Health Secretary Robert F. Kennedy Jr. has ordered an American passenger exposed to hantavirus on a cruise ship to remain in quarantine despite medical advice and...

Experts outline the clinical features that may signal rare genetic disorders, helping pediatricians identify affected children, and accelerate specialist referrals.

The co-occurrence of IBD and Clostridioides difficile poses unique diagnostic and management challenges. A new American Gastroenterological Association statement updates earlier 2017 guidance.

A profound lack of anatomical research into the clitoris has left the medical community blind to the root causes of postpartum nerve damage and chronic pelvic pain.

Health workers battling an Ebola outbreak in eastern Democratic Republic of Congo lack the personnel to identify suspected cases, the ambulances to transport them and even...

News All Time

Reducing Readmissions: What Works?

With more hospitals expected to face readmission penalties, hospitals continue efforts to decrease readmissions. Two programs that focus on keeping in touch with patients postdischarge are helping.

Sound Wave Therapy Improves Kids’ Congestion

High adherence and absence of adverse events support the feasibility of nondrug treatment.

Promising Results for Sonelokimab in Early-Phase axSpA Trial

Results of the phase 2, open-label, single-arm S-OLARIS study provide ‘proof of concept’ that the novel IL-17A/F-inhibiting nanobody has an effect on patients with axial spondyloarthritis.

Now We Can Remove Microplastics From the Body: Does It Help?

Researchers used a basic procedure to lower microplastic levels in the body, but no one knows if this benefits the patient or how long until new plastics leach back in.

Peanut Allergy Labels Removed in One Third of Infants

Formal food challenges before oral immunotherapy allowed early delabelling of peanut allergy in more than one third of Australian infants despite prior reactions and evidence of sensitization.

Wearable Diabetes Devices: Triggers Behind Most Dermatitis

A patch-testing study highlights the compounds that account for most of the contact dermatitis from insulin infusion and glucose monitoring devices.

Adrenaline Falls Short in Anaphylaxis Model

Standard intramuscular adrenaline doses failed to restore blood pressure in most participants exposed to a controlled histamine challenge mimicking severe anaphylaxis.

Nipocalimab Outshines Placebo in Phase 2b Lupus Study

A higher percentage of participants treated with nipocalimab 15 mg/kg met the primary endpoint of an SLE Responder Index-4 composite response at week 24 than placebo.

Unusually Warm Canadian Temperatures a Harbinger of Ticks

Experts warn that new tick species in Canada can confound diagnosis.

Health Workers Struggle to Contain Ebola in Congo Camps as Distrust Grows

After the Kpangba displacement camp became the first in this part of war-torn Congo to record deaths from Ebola two weeks ago, health ⁠workers rushed to trace those who had...

Immigrant Docs at Center of Storm as Court Battles Intensify

Rapid changes to federal immigration policy including travel bans mean uncertain futures for many immigrant physicians and medical students hoping to enter or remain in the US.

Jazz Pharmaceuticals Lung Cancer Drug Fails Main Trial Goal

Jazz Pharmaceuticals said on Friday its lung cancer drug Zepzelca failed to meet the main goal ⁠of improving overall survival in a late-stage study, potentially risking its...

New Score May Improve Pediatric Anaphylaxis Care

A new risk score stratifies children’s risk for biphasic anaphylaxis and could reduce unnecessary emergency department observation for most patients.

Four JAK Inhibitors Have Positive Late-Stage Trial Results

Data from phase 3 studies with filgotinib, gecacitinib, and ivarmacitinib and a phase 4 study of tofacitinib in early disease are reported.

Nasal Steroids May Not Affect Treatment Response in EoE

The concurrent use of intranasal and/or inhaled steroids or coexisting allergic rhinitis does not affect treatment response in patients with eosinophilic esophagitis receiving topical corticosteroids.

SAT Offers Hope for Prosthetic Vascular Graft Infection Care

Suppressive antimicrobial therapy is a viable option for patients with prosthetic vascular graft infection who are at a high surgical risk.

Recommended News For You

No Solace From Drug Scarcities; Novel Guidelines Regarding Lymphedema; A "Good" Patient Is Forgotten.

Immunotherapy Is As Safe As Other Cancer Treatments During Pregnancy.

Cancer during young adulthood carries long-term mental toll, study finds

Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation

Inside the Major Findings From the NHS-Galleri Trial

Predicting adult mortality from oral cancer using a machine learning approach.

Kate Middleton and Remission: Oncologists Weigh In

Recommended Articles For You

Enhancing Cancer Care: From Diagnosis Through Survivorship and Beyond 

Understanding Phyllodes Tumor: Symptoms, Diagnosis, and Treatment Options 

Expanding Oncology Frontiers: Rare Cancers, Breakthroughs, and Precision Medicine Advances 

Beyond Immunotherapy: Emerging Novel Treatments for Small Cell Lung Cancer 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

2.

In early dementia, SSRIs enhance cognition and major depression.

3.

FDA Approves CAR-T Product Use for Myeloma Early.

4.

For Localized Prostate Cancer, HIFU Is Not Worse Than Prostatectomy.

5.

CD39 Blockade Shows Potential in Early-Stage Lung Cancer

1.

Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes

2.

Understanding Hidrocystoma: Symptoms, Causes, and Treatment Options 

3.

Unveiling the Chadwick Sign: A Revolutionary New Tool for Detecting Early Signs of Cancer

4.

Living with Shwachman-Diamond Syndrome: A Journey of Hope and Strength

5.

Understanding Verrucous Carcinoma: Symptoms, Diagnosis, and Treatment Options

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II

2.

The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.

3.

Managing CNS diseases at the point of diagnosis in ALK + NSCLC

4.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II

5.

Thromboprophylaxis In Medical Settings

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot